Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Assets (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Assets for 15 consecutive years, with $71.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Assets fell 19.72% year-over-year to $71.1 million, compared with a TTM value of $71.1 million through Sep 2025, down 19.72%, and an annual FY2024 reading of $88.1 million, up 19.25% over the prior year.
  • Assets was $71.1 million for Q3 2025 at Sanara MedTech, down from $98.8 million in the prior quarter.
  • Across five years, Assets topped out at $98.8 million in Q2 2025 and bottomed at $33.9 million in Q1 2022.
  • Average Assets over 5 years is $64.4 million, with a median of $70.9 million recorded in 2024.
  • The sharpest move saw Assets skyrocketed 309.64% in 2021, then dropped 19.72% in 2025.
  • Year by year, Assets stood at $36.4 million in 2021, then soared by 67.7% to $61.0 million in 2022, then increased by 21.03% to $73.9 million in 2023, then grew by 19.25% to $88.1 million in 2024, then dropped by 19.3% to $71.1 million in 2025.
  • Business Quant data shows Assets for SMTI at $71.1 million in Q3 2025, $98.8 million in Q2 2025, and $96.4 million in Q1 2025.